Does ALS Cause Neuropathy? How to Tell Them Apart

ALS does not cause neuropathy in the traditional sense, but the line between the two conditions is blurrier than most people realize. ALS is classified as a motor neuron disease, meaning the nerve cells themselves are dying, while neuropathy involves damage to the nerve fibers that carry signals. Yet research consistently shows that a significant number of ALS patients develop measurable nerve fiber changes that look a lot like neuropathy, particularly in sensory nerves that shouldn’t be affected at all.

How ALS and Neuropathy Differ

The core distinction comes down to where the damage happens. In ALS, motor neurons in the brain and spinal cord progressively die. These are the cells that generate the electrical signals telling your muscles to move. In neuropathy, the neurons themselves may be intact, but the long nerve fibers (axons) that carry those signals are damaged or degraded. One analogy: ALS is like the battery dying in a car, while neuropathy is like the roads being blocked.

This distinction matters because it shapes what you feel. ALS is fundamentally about weakness. Muscles stop working because the neurons commanding them are gone. Neuropathy, by contrast, often involves numbness, tingling, burning, or pain because sensory nerve fibers are affected. If you’re experiencing prominent numbness or burning pain, that pattern points more toward neuropathy than ALS.

Sensory Nerve Damage in ALS Is More Common Than Expected

For decades, ALS was considered a purely motor disease. Sensory nerves were supposed to be spared. That understanding has shifted considerably. A systematic review covering 728 ALS patients across 10 studies found that about 20% had detectable sensory neuropathy, and roughly 8% had clinical sensory symptoms like tingling or numbness. The numbers vary depending on how you look: standard nerve conduction testing picks up abnormalities in about 16% of ALS patients, while more sensitive methods like nerve biopsy detect changes in over 80%.

A study of 103 ALS patients found that nearly 30% had sensory symptoms and abnormal nerve conduction results in their legs. When researchers biopsied leg sensory nerves in a separate group, 91% showed tissue-level abnormalities. In another study examining 32 ALS patients, nerve conduction tests appeared normal, but biopsies revealed abnormal axonal swelling in every single patient. The damage is there; it just doesn’t always show up on standard testing or produce noticeable symptoms.

Small Fiber Neuropathy in ALS

One of the more striking findings involves small fiber neuropathy, which affects the thin nerve endings in your skin responsible for pain and temperature sensation. In a study comparing ALS patients to healthy controls, 79% of ALS patients met criteria for small fiber neuropathy based on skin biopsies from the lower leg, compared to just 12% of controls. The ALS group had dramatically reduced nerve fiber density: about 4.8 fibers per millimeter versus 12.2 in healthy people.

Researchers also found unusual swellings in the tiny nerve fibers of ALS patients, suggesting problems with how materials are transported along the length of the nerve. This supports a concept called distal axonopathy, where the far ends of nerve fibers degenerate first. Seven of those ALS patients reported mild sensory symptoms including diffuse tingling, numbness, and altered skin sensation. So while ALS is not classified as a neuropathy, the disease process does appear to reach into peripheral sensory nerves in a substantial proportion of patients.

Why ALS Affects Peripheral Nerves

Motor nerve biopsies from ALS patients consistently show signs of active nerve fiber damage, focal fiber loss, and very little regeneration. This last point is key. In typical neuropathies, nerves at least attempt to regrow and repair. In ALS, that regenerative capacity is largely absent, which is one reason the disease progresses relentlessly.

The leading explanation is that ALS involves a “dying back” process. Motor neurons are some of the longest cells in the body, with axons stretching from the spinal cord all the way to muscles in the feet. When the cell body becomes sick, the farthest reaches of the axon deteriorate first. This same process appears to affect sensory neurons to a lesser degree, which explains why sensory nerve damage shows up in biopsies even when patients don’t report numbness or pain.

Genetic Forms With Prominent Neuropathy

Certain inherited forms of ALS include sensory neuropathy as a recognized feature. Familial ALS linked to a specific mutation in the SOD1 gene can present with both urinary changes and sensory neuropathy. A mutation in the TARDBP gene has been associated with confirmed sensory nerve damage on biopsy. There is also a related condition called FOSMN syndrome (facial-onset sensory motor neuropathy) that begins with facial numbness before progressing to motor neuron involvement. While FOSMN is technically a separate diagnosis, mutations in SOD1 have been found in some of these patients, suggesting overlap with classical ALS.

These variants are uncommon, but they illustrate that the boundary between ALS and neuropathy is not absolute. The umbrella of motor neuron disease includes presentations where sensory nerves are clearly part of the picture.

ALS Is Frequently Misdiagnosed as Neuropathy

The symptom overlap between early ALS and neuropathy creates a real diagnostic challenge. Across multiple studies, 31% to 52% of ALS patients received at least one incorrect diagnosis before ALS was identified. Neuropathy is one of the most common misdiagnoses. In one study of 304 patients, 28% were initially told they had a neuropathy. Other studies report neuropathy misdiagnosis rates between 3% and 9%, with related conditions like carpal tunnel syndrome and radiculopathy also appearing frequently on the list.

This happens because early ALS can look like a pinched nerve or a peripheral nerve problem: weakness in one hand, foot drop, muscle cramps. The features that eventually distinguish ALS, such as widespread muscle wasting, fasciculations across multiple body regions, and the combination of upper and lower motor neuron signs, may not be obvious in the first months.

How Testing Tells Them Apart

Electrodiagnostic testing is the primary tool for distinguishing ALS from neuropathy. Two features are especially important.

First, sensory nerve responses should be normal in ALS. The signals traveling through sensory nerves (measured as sensory nerve action potentials) are preserved because the dorsal root ganglion, the cluster of sensory nerve cell bodies near the spinal cord, is typically spared. If sensory responses are clearly abnormal, that points toward a peripheral neuropathy, plexopathy, or another condition rather than ALS.

Second, ALS does not produce conduction blocks. A conduction block means the electrical signal gets stuck partway along a nerve fiber, which is a hallmark of demyelinating neuropathies like multifocal motor neuropathy. In ALS, signals either get through or the nerve fiber is gone entirely. Finding conduction blocks on testing should prompt consideration of a treatable neuropathy that can mimic ALS.

Motor nerve conduction studies in ALS typically show reduced signal strength from the muscles, reflecting the loss of motor neurons. The signals that do get through may travel slightly slower than normal, but the pattern is one of axonal loss rather than the dramatic slowing seen in demyelinating conditions. Needle examination (EMG) reveals widespread denervation, with muscle fibers firing spontaneously because they’ve lost their nerve supply. The combination of these findings across multiple body regions, with normal sensory responses, is the electrodiagnostic signature of ALS.

Symptoms That Overlap and Symptoms That Don’t

Both ALS and neuropathy can cause muscle twitching, cramps, weakness, and loss of muscle mass. Both can affect balance and coordination. This overlap is what makes the early stages confusing for patients and clinicians alike.

The distinguishing symptoms lean in opposite directions. ALS is dominated by progressive weakness that spreads from one region to another: a weak hand becomes a weak arm, then the other arm, then the legs or speech muscles. Neuropathy is more likely to produce positive sensory symptoms like burning pain, stabbing sensations, pins and needles, and numbness, typically starting in the feet and hands. If your primary complaint is pain or numbness rather than weakness, neuropathy is the more likely explanation. If weakness is progressing without significant sensory changes, ALS enters the picture.

That said, up to a third of ALS patients do report some sensory symptoms. These tend to be mild, diffuse, and overshadowed by the motor symptoms. They’re not the kind of severe burning foot pain that drives someone to search for answers about neuropathy. When sensory symptoms are prominent and the primary concern, a peripheral neuropathy or another condition is far more likely than ALS.